Drug General Information
Drug ID
D04BCG
Former ID
DNC000882
Drug Name
LLZ16407
Indication Discovery agent Investigative [535353]
Target and Pathway
Target(s) Mitogen-activated protein kinase kinase kinase 2 Target Info Inhibitor [535353]
KEGG Pathway MAPK signaling pathway
Gap junction
GnRH signaling pathway
NetPath Pathway IL5 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
TCR Signaling Pathway
PANTHER Pathway B cell activation
EGF receptor signaling pathway
FGF signaling pathway
Pathway Interaction Database ErbB1 downstream signaling
Trk receptor signaling mediated by the MAPK pathway
WikiPathways Insulin Signaling
EGF/EGFR Signaling Pathway
MAPK Cascade
MAPK Signaling Pathway
BDNF signaling pathway
IL-1 signaling pathway
References
Ref 535353Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.
Ref 535353Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.